European Medicines Evaluation Agency bans dextropropoxyphene: a landmark decision for clinical toxicology?
Royal Infirmary of Edinburgh, Edinburgh, UK. nick.bateman@luht.scot.nhs.uk
Nicholas D
ND
Bateman
Euan A
EA
Sandilands
D000082:Acetaminophen / Q000506:poisoning*; D000701:Analgesics, Opioid / Q000506:poisoning*; D003257:Consumer Product Safety; D011431:Dextropropoxyphene / Q000506:poisoning*; D004338:Drug Combinations; D062787:Drug Overdose / Q000517:prevention & control; D004335:Drug and Narcotic Control; D005060:Europe; D033161:Government Regulation; D006801:Humans; D011039:Poison Control Centers; D055553:Prescription Drugs / Q000506:poisoning*; D018570:Risk Assessment; D014116:Toxicology / Q000331:legislation & jurisprudence*; D000092864:Suicide Prevention
D000701:Analgesics, Opioid; D004338:Drug Combinations; D055553:Prescription Drugs; D000082:Acetaminophen; C011800:acetaminophen, dextropropoxyphene, drug combination; D011431:Dextropropoxyphene